Research Focus

Former Employee. Graduate Staff; NE Rotating Housestaff

Recent additions – View all

1. Phase II study of first-line trebananib plus sorafenib in patients with advanced hepatocellular carcinoma (HCC)

   Meeting Abstract

   Abou-Alfa, G. K.; Blanc, J. F.; Miles, S.; Ganten, T. M.; Trojan, J.; Cebon, J. S.; Liem, A. K. D.; Lipton, L. R.; Gupta, C.; Wu, B.; more...
   Journal of Clinical Oncology (2014)

   Fulltext@MSK | Save